{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:02:45Z","timestamp":1784635365187,"version":"3.55.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Colorectal cancer (CRC) develops within a mucosal ecosystem where the microbiota, epithelial barrier, and group 3 innate lymphoid cells (ILC3) jointly shape immune tone. ILC3 plasticity spans both tissue-protective and inflammatory states, and MHC II-dependent antigen presentation-like activity of ILC3 is associated with microbiota-directed CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell and IgA responses. In CRC, chronic inflammation and dysbiosis drive a shift toward barrier-damaging ILC3 programs, attenuate epithelial antimicrobial defenses, and defocus microbiota-directed immunity. These alterations correlate with more aggressive tumor behavior and poorer responses to immune checkpoint therapy. We integrate this evidence into a feed-forward model in which impaired crosstalk among ILC3, the epithelium, and the microbiota promotes barrier weakening, inflammatory amplification, and tumor progression. Within this framework, we propose biomarker panels that capture ILC3 state, barrier integrity, and DEFB1 expression, together with therapeutic strategies targeting cytokine pathways, metabolism, microbiota structure, and immune checkpoints.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1783909","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:45:22Z","timestamp":1780983922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasticity and antigen presentation by group 3 innate lymphoid cells in colorectal cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Lu","family":"Qiao","sequence":"first","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"He","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkun","family":"Lu","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesi","family":"Tao","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxian","family":"Cui","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Bao","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2025.0762","article-title":"Microbiota-host interaction in colorectal cancer: emerging computational technology, multi-omics integration, and mechanisms","volume":"20250762","author":"Lu","year":"2026","journal-title":"Cancer Biol Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"113193","DOI":"10.1016\/j.intimp.2024.113193","article-title":"ChanLingGao alleviates intestinal mucosal barrier damage and suppresses the onset and progression of colorectal cancer in AOM\/DSS murine model","volume":"143","author":"Tian","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.96338","article-title":"Bridging chronic inflammation and digestive cancer: The critical role of innate lymphoid cells in tumor microenvironments","volume":"20","author":"Shen","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-025-67169-7","article-title":"Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state","volume":"17","author":"Bersier","year":"2026","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/s41467-022-29027-8","article-title":"Immunosuppressive niche engineering at the onset of human colorectal cancer","volume":"13","author":"Gatenbee","year":"2022","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1687556","article-title":"Immunological landscape of colorectal cancer: tumor microenvironment, cellular players and immunotherapeutic opportunities","volume":"12","author":"Andac-Aktas","year":"2025","journal-title":"Front Mol Biosci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00906-3","article-title":"Group 3 innate lymphoid cells in intestinal health and disease","volume":"21","author":"Horn","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1033252","article-title":"Innate lymphoid cells type 3 in cancer","volume":"13","author":"Castillo-Gonz\u00e1lez","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1016\/j.cell.2021.07.029","article-title":"Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer","volume":"184","author":"Goc","year":"2021","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886520","article-title":"Plasticity of innate lymphoid cells in cancer","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13322","article-title":"Group 3 innate lymphoid cells: A trained gutkeeper","volume":"323","author":"Serafini","year":"2024","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0775","article-title":"Human NKp44+ group 3 innate lymphoid cells associate with tumor-associated tertiary lymphoid structures in colorectal cancer","volume":"8","author":"Ikeda","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1171826","article-title":"The role of group 3 innate lymphoid cell in intestinal disease","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.08.002","article-title":"ILC3 plasticity in microbiome-mediated tumor progression and immunotherapy","volume":"39","author":"Shen","year":"2021","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235967","article-title":"Immune checkpoints and innate lymphoid cells\u2014New avenues for cancer immunotherapy","volume":"13","author":"Jacquelot","year":"2021","journal-title":"Cancers"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11020461","article-title":"Innate lymphoid cell plasticity in mucosal infections","volume":"11","author":"Korchagina","year":"2023","journal-title":"Microorganisms"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav1080","article-title":"IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis","volume":"5","author":"Bauch\u00e9","year":"2020","journal-title":"Sci Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s40168-024-01995-7","article-title":"Live Akkermansia muciniphila boosts dendritic cell retinoic acid synthesis to modulate IL-22 activity and mitigate colitis in mice","volume":"12","author":"Liu","year":"2024","journal-title":"Microbiome"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580467","article-title":"Metabolic regulation of group 3 innate lymphoid cells and their role in inflammatory bowel disease","volume":"11","author":"Song","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02240-5","article-title":"Circadian circuits control plasticity of group 3 innate lymphoid cells by sustaining epigenetic configuration of ROR\u03b3t","volume":"26","author":"Bhattarai","year":"2025","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.623324","article-title":"T-Bet controls cellularity of intestinal group 3 innate lymphoid cells","volume":"11","author":"Schroeder","year":"2020","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52549","article-title":"c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells","volume":"9","author":"Tizian","year":"2020","journal-title":"eLife"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211861","article-title":"Group 3 innate lymphoid cells require BATF to regulate gut homeostasis in mice","volume":"219","author":"Wu","year":"2022","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13156","article-title":"Innate lymphoid cells in colorectal cancer","volume":"95","author":"Marchalot","year":"2022","journal-title":"Scand J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320908","article-title":"Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma","volume":"69","author":"Carrega","year":"2020","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100353","article-title":"Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression","volume":"2","author":"Qi","year":"2021","journal-title":"Cell Rep Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01284-1","article-title":"Inflammation triggers ILC3 patrolling of the intestinal barrier","volume":"23","author":"Jarade","year":"2022","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1134636","article-title":"Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S512652","article-title":"Deciphering the role of innate lymphoid cells group 3 in the gut microenvironment: A narrative review of their novel contributions to autoimmune disease pathogenesis","volume":"18","author":"Wang","year":"2025","journal-title":"J Inflammation Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-06-0294","article-title":"Human \u03b2-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma","volume":"66","author":"Sun","year":"2006","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1538-7445.AM2013-1526","article-title":"Evaluation of the novel tumor suppressor gene, \u03b2-Defensin-1, in colorectal cancer cell line models","volume":"73","author":"Layton","year":"2013","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2024.04.01","article-title":"Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma","volume":"36","author":"Duan","year":"2024","journal-title":"Chin J Cancer Res"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3523","article-title":"DEFB1 gene expression and the molecular landscape of colorectal cancer (CRC)","author":"Lo","year":"2022"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2318710120","article-title":"A distinct human cell type expressing MHCII and ROR\u03b3t with dual characteristics of dendritic cells and type 3 innate lymphoid cells","volume":"120","author":"Ulezko Antonova","year":"2023","journal-title":"PNAS"},{"key":"B36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12958-022-00979-2","article-title":"Oxygen regulates ILC3 antigen presentation potential and pregnancy-related hormone actions","volume":"20","author":"Einenkel","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17014","article-title":"The crosstalk between ILC3s and adaptive immunity in diseases","volume":"291","author":"Wang","year":"2024","journal-title":"FEBS J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2023.10.021","article-title":"The interaction network between group 3 innate lymphoid cells and other cells","volume":"5","author":"Hu","year":"2023","journal-title":"Fundam Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxac054","article-title":"The thin line between conventional dendritic cells (cDCs) and group 3 innate lymphoid cells (ILC3s) in the gut","volume":"35","author":"Ulezko Antonova","year":"2023","journal-title":"Int Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mucimm.2023.07.001","article-title":"Bcl-2 supports survival and metabolic fitness of quiescent tissue-resident ILC3","author":"King","year":"2023","journal-title":"Mucosal Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/eji.70103","article-title":"The antigen presenting capabilities of group 3 innate lymphoid cells: insights into immunogenic or tolerogenic outcomes for T cells","volume":"55","author":"Calabr\u00f2","year":"2025","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140678","article-title":"CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22","volume":"211","author":"Longman","year":"2014","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239254","article-title":"Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells","volume":"21","author":"Pietrzak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180871","article-title":"Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria","volume":"216","author":"Melo-Gonzalez","year":"2019","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4812","article-title":"Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4\u207a T cells","volume":"348","author":"Hepworth","year":"2015","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00399-23","article-title":"The interplay between innate lymphoid cells and microbiota","volume":"14","author":"Wang","year":"2023","journal-title":"mBio"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1316","article-title":"Commensal microbiome and gastrointestinal mucosal immunity: Harmony and conflict with our closest neighbor","volume":"12","author":"Tian","year":"2024","journal-title":"Immun Inflammation Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05089-y","article-title":"A ROR\u03b3t+ cell instructs gut microbiota-specific Treg cell differentiation","volume":"610","author":"Kedmi","year":"2022","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112800","article-title":"The transcription factor IRF4 regulates the homeostasis and function of intestinal ILC3s","volume":"28","author":"Gao","year":"2025","journal-title":"iScience"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.758730","article-title":"The Pathogenic Roles of IL-22 in Colitis: Its Transcription Regulation by Musculin in T Helper Subsets and Innate Lymphoid Cells","volume":"12","author":"Yan","year":"2021","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05309-5","article-title":"Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota","volume":"610","author":"Akagbosu","year":"2022","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112893","article-title":"Crosstalk between ILC3s and microbiota: Implications for colon cancer development and treatment with immune check point inhibitors","volume":"15","author":"Drommi","year":"2023","journal-title":"Cancers"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271699","article-title":"ILC3: A case of conflicted identity","volume":"14","author":"Koprivica","year":"2023","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042021","article-title":"Understanding type 3 innate lymphoid cells and crosstalk with the microbiota: A skin connection","volume":"25","author":"To","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2390135","article-title":"Microbiota and plasticity of antigen-presenting ILC3s: Impact on antitumor immune response","volume":"16","author":"Calabr\u00f2","year":"2024","journal-title":"Gut Microbes"},{"key":"B57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mib.2021.06.005","article-title":"Group 3 innate lymphoid cells mediate host defense against attaching and effacing pathogens","volume":"63","author":"Jarade","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e70041","DOI":"10.1002\/eji.70041","article-title":"Cellular Cosmetics: How Innate Lymphoid Cells Can Recontour the Tumour Microenvironment","volume":"55","author":"Pun","year":"2025","journal-title":"Eur J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12697","article-title":"Functional and phenotypic heterogeneity of group 3 innate lymphoid cells","volume":"150","author":"Melo-Gonzalez","year":"2017","journal-title":"Immunology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1159\/000546972","article-title":"Interaction between group 3 innate lymphoid cells, microbiota and intestinal diseases: Mechanisms and therapeutic potential","volume":"17","author":"Hao","year":"2025","journal-title":"J Innate Immun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.mucimm.2023.12.002","article-title":"MZB1-mediated IgA secretion suppresses the development and progression of colorectal cancer triggered by gut inflammation","volume":"17","author":"Tang","year":"2024","journal-title":"Mucosal Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41392-023-01553-x","article-title":"Mechanisms and regulation of defensins in host defense","volume":"8","author":"Fu","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084562","article-title":"Change in tissue microbiome and related human beta defensin levels induced by antibiotic use in bladder carcinoma","volume":"25","author":"Mony\u00f3k","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.04.002","article-title":"Human beta-defensin 1 circulating level and gene polymorphism in non-segmental vitiligo Egyptian patients","volume":"98","author":"Farag","year":"2023","journal-title":"Anais Brasileiros Dermatologia"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609689","article-title":"Local stabilization of hypoxia-inducible factor-1\u03b1 controls intestinal inflammation via enhanced gut barrier function and immune regulation","volume":"11","author":"Kim","year":"2020","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00574-z","article-title":"Resistance is futile? Mucosal immune mechanisms in the context of microbial ecology and evolution","volume":"15","author":"Slack","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1668173","article-title":"The AhR\/IL-22 axis in chronic gut inflammation: Unraveling mechanisms and therapeutic prospects","volume":"16","author":"Kang","year":"2025","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1559521","article-title":"Understanding dysbiosis and resilience in the human gut microbiome","volume":"16","author":"Safarchi","year":"2025","journal-title":"Front Microbiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103505","article-title":"Evaluation of defensins as markers of gut microbiota disturbances in children with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"14","author":"Wierzbicka-Ruci\u0144ska","year":"2025","journal-title":"J Clin Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2321836121","article-title":"Deficiency of IL-22\u2013binding protein enhances the ability of IL-22 to protect the colon from pathogenic bacteria","volume":"121","author":"Fachi","year":"2024","journal-title":"PNAS"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2019.10.004","article-title":"Molecular signature of interleukin-22 in colon carcinoma cells and organoid models","volume":"216","author":"Rudloff","year":"2020","journal-title":"Trans Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i8.108535","article-title":"Interleukin-22 promotes cancer stemness and chemotherapy resistance in colorectal cancer via epidermal growth factor receptor\/extracellular signal-regulated kinase pathway","volume":"17","author":"Ruan","year":"2025","journal-title":"World J Gastrointestinal Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239732","article-title":"The clinical relevance of OSM in inflammatory diseases: A comprehensive review","volume":"14","author":"Wolf","year":"2023","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: Molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1655730","article-title":"Innate lymphoid cells in the spotlight: From biomarkers to blueprint for innovative immunotherapy","volume":"16","author":"Kuo","year":"2025","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.mucimm.2024.03.002","article-title":"PD-1 regulates ILC3-driven intestinal immunity and homeostasis","volume":"17","author":"Jacquelot","year":"2024","journal-title":"Mucosal Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51719-6","article-title":"CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner","volume":"15","author":"Lo","year":"2024","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.immuni.2024.05.004","article-title":"Intestinal CXCR6+ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression","volume":"57","author":"Liang","year":"2024","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2528428","article-title":"Secretory IgA dysfunction underlies poor prognosis in Fusobacterium-infected colorectal cancer","volume":"17","author":"Choi","year":"2025","journal-title":"Gut Microbes"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01923-9","article-title":"Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteria","volume":"12","author":"van Gogh","year":"2024","journal-title":"Microbiome"},{"key":"B81","doi-asserted-by":"publisher","first-page":"103807","DOI":"10.1016\/j.autrev.2025.103807","article-title":"Interaction between gut microbiota and T cell immunity in colorectal cancer","volume":"24","author":"Jing","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05860-x","article-title":"HAS-CIRCpedia-5280 sponges miR-4712-5p to regulate human \u03b2-defensin-1\u2013induced autophagy and inhibit colon cancer progression","volume":"23","author":"An","year":"2025","journal-title":"J Transl Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002329","article-title":"Dysbiosis and colorectal\u00a0cancer: Conducive factors, biological and molecular role, and therapeutic prospectives","volume":"6","author":"Singh","year":"2025","journal-title":"Explor Targeted Anti-tumor Ther"},{"key":"B84","doi-asserted-by":"publisher","first-page":"11795549221130549","DOI":"10.1177\/11795549221130549","article-title":"The Association Between Gut Microbiota, Toll-Like Receptors, and Colorectal Cancer","volume":"16","author":"Fang","year":"2022","journal-title":"Clin Med Insights Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.10.012","article-title":"Targeting the interleukin-23 pathway in inflammatory bowel disease","volume":"168","author":"Bourgonje","year":"2025","journal-title":"Gastroenterology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1543210","article-title":"Bidirectional regulation of the gut microbiome\u2013immune axis in colorectal cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0312-y","article-title":"Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1862529","DOI":"10.1080\/2162402X.2020.1862529","article-title":"Tumor immune infiltration estimated from gene expression profiles predicts colorectal\u00a0cancer relapse","volume":"10","author":"Kamal","year":"2021","journal-title":"Oncoimmunology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-0137","article-title":"The ratio of exhausted to resident infiltrating lymphocytes is prognostic for colorectal cancer patient outcome","volume":"9","author":"Foroutan","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.62347\/IOAM8718","article-title":"Correlation of Th17\/Treg associated transcription factors with clinicopathological features of colorectal cancer and their prognostic significance","volume":"16","author":"Pan","year":"2024","journal-title":"Am J Transl Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1175513","article-title":"Cytokine concentration in peripheral blood of patients with colorectal cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"12968","DOI":"10.3390\/ijms232112968","article-title":"Old and new blood markers in human colorectal cancer","volume":"23","author":"Wautier","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1105145","article-title":"A cis-element at the Rorc locus regulates the development of type 3 innate lymphoid cells","volume":"14","author":"Chang","year":"2023","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00451-w","article-title":"Clinical trials of IL-12\/IL-23 inhibitors in inflammatory bowel disease","volume":"34","author":"Almradi","year":"2020","journal-title":"BioDrugs"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e00578","DOI":"10.14309\/ctg.0000000000000578","article-title":"Mirikizumab regulates genes involved in ulcerative colitis disease activity and anti-TNF resistance: results from a phase 2 study","volume":"14","author":"Steere","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.670632","article-title":"Dietary derived micronutrients modulate immune responses through innate lymphoid cells","volume":"12","author":"Shi","year":"2021","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2024.04.008","article-title":"The role of the aryl hydrocarbon receptor (AhR) in modulating intestinal ILC3s to optimise gut pathogen resistance in lupus and benefits of nutritional AhR ligands","volume":"43","author":"Hanlon","year":"2024","journal-title":"Clin Nutr"},{"key":"B98","doi-asserted-by":"publisher","first-page":"578489","DOI":"10.1016\/j.jneuroim.2024.578489","article-title":"Retinoic acid modulates peripheral blood helper innate lymphoid cell composition in vitro in patients with multiple sclerosis","volume":"398","author":"\u00d6zko\u015far","year":"2025","journal-title":"J Neuroimmunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328387","article-title":"Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis","volume":"72","author":"Wagner","year":"2023","journal-title":"Gut"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00192.2020","article-title":"Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of \u03b1-integrin expression and function","volume":"320","author":"Goggins","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.11.005","article-title":"Protective role of spermidine in colitis and colon carcinogenesis","volume":"162","author":"Gobert","year":"2022","journal-title":"Gastroenterology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1039\/d1fo01008e","article-title":"Alhagi honey polysaccharides attenuate intestinal injury and immune suppression in cyclophosphamide-induced mice","volume":"12","author":"Cai","year":"2021","journal-title":"Food Funct"},{"key":"B103","doi-asserted-by":"publisher","first-page":"118014","DOI":"10.1016\/j.biopha.2025.118014","article-title":"Combination therapy with immune checkpoint inhibitors in colorectal cancer: challenges, resistance mechanisms, and the role of microbiota","volume":"186","author":"Rahimi","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"B104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13099-025-00734-z","article-title":"Gut microbiome in gastrointestinal neoplasms: from mechanisms to precision therapeutic strategies","volume":"17","author":"Song","year":"2025","journal-title":"Gut Pathog"},{"key":"B105","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-024-01785-6","article-title":"Blockade of C5aR1 resets M1 via gut microbiota-mediated PFKM stabilization in a TLR5-dependent manner","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e080377","DOI":"10.1136\/bmjopen-2023-080377","article-title":"Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol","volume":"14","author":"Geng","year":"2024","journal-title":"BMJ Open"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2348254","DOI":"10.1080\/2162402X.2024.2348254","article-title":"Memory-like differentiation enhances NK cell responses against colorectal cancer","volume":"13","author":"Marin","year":"2024","journal-title":"Oncoimmunology"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2021.08.004","article-title":"Innate lymphoid cells and gastrointestinal disease","volume":"48","author":"Wang","year":"2021","journal-title":"J Genet Genomics"},{"key":"B109","doi-asserted-by":"publisher","first-page":"eado8395","DOI":"10.1126\/scitranslmed.ado8395","article-title":"Synthetic biology-driven induction\u00a0of mature TLS formation enhances antitumor immunity in colorectal cancer","volume":"17","author":"Mi","year":"2025","journal-title":"Sci Transl Med"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1922676","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1783909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:20:30Z","timestamp":1784632830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1783909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":109,"alternative-id":["10.3389\/fimmu.2026.1783909"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1783909","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1783909"}}